Maxime Pichon, Christophe Burucoa. Impact of the Gastro-Intestinal Bacterial Microbiome on Helicobacter-Associated Diseases. Healthcare, MDPI, 2019, 7 (1), pp.34. ⟨10.3390/healthcare7010034⟩. ⟨hal-02132973⟩
Antonin Bal, Maxime Pichon, Caroline Picard, Jean-Sébastien Casalegno, Martine Valette, et al.. Quality control implementation for universal characterization of DNA and RNA viruses in clinical respiratory samples using single metagenomic next-generation sequencing workflow. BMC Infectious Diseases, BioMed Central, 2018, 18 (1), pp.537. ⟨10.1186/s12879-018-3446-5⟩. ⟨inserm-02044167⟩
Alexandre Gaymard, Maude Bouscambert-Duchamp, Maxime Pichon, Emilie Frobert, Julien Vallée, et al.. Genetic characterization of respiratory syncytial virus highlights a new BA genotype and emergence of the ON1 genotype in Lyon, France, between 2010 and 2014. Journal of Clinical Virology, Elsevier, 2018, 102, pp.12 - 18. ⟨10.1016/j.jcv.2018.02.004⟩. ⟨hal-01920887⟩
Maxime Pichon, Bruno Lina, Laurence Josset. Impact of the Respiratory Microbiome on Host Responses to Respiratory Viral Infection. Vaccines, MDPI, 2017, 5 (4), ⟨10.3390/vaccines5040040⟩. ⟨hal-01911413⟩
Maxime Pichon, Alexandre Gaymard, Laurence Josset, Martine Valette, Gilles Millat, et al.. Characterization of oseltamivir-resistant influenza virus populations in immunosuppressed patients using digital-droplet PCR: Comparison with qPCR and next generation sequencing analysis. Antiviral Research, Elsevier Masson, 2017, 145, pp.160-167. ⟨10.1016/j.antiviral.2017.07.021⟩. ⟨hal-01908998⟩
Stanley Langevin, Maxime Pichon, Elise Smith, Juliet Morrison, Zachary Bent, et al.. Early nasopharyngeal microbial signature associated with severe influenza in children: a retrospective pilot study. Journal of General Virology, Microbiology Society, 2017, 98 (10), pp. 2425-2437. ⟨10.1099/jgv.0.000920⟩. ⟨hal-01909982⟩
Alexandre Gaymard, Maxime Pichon, Michaël Degaud, Jason Tasse, Céline Dupieux, et al.. Methicillin-resistant Staphylococcus aureus in the environment of public transport: data from the metropolitan network in Lyon, France. International Journal of Antimicrobial Agents, Elsevier, 2016, 48 (4), pp.459-462. ⟨10.1016/j.ijantimicag.2016.07.012⟩. ⟨hal-01911533⟩
Dr Maxime PICHON (born 03.06.1988) is associate professor of microbiology at the university of Poitiers, School of Medicine and Pharmacy ; and Hospital Practitionner at the Poitiers University Hospital, France.
Member of the INSERM unit U1070 « Pharmacology of Antimicrobial Agents », he received his MD (2017) from the University Claude Bernard Lyon 1 and his Ph.D (2018) in Physiology, Biology and Interactions of the Organisms, with a Specialisation in Bacteriology and Virology, from the University of Lyon, Saint Etienne and the Ecole Normale Supérieure, after conducting his doctoral reserch with Prof Dr. B . Lina in the National Reference Center on Influenza.
He has published 23 articles and book chapters (H-index =7 and i10 score = 4 according to Google Scholar) and was co-director of two master students, one Ph.D. student, and numerous medical residents.
He has organized the annual congresses of the French Microbiology Society (SFM) since 2018, when he founded the Young Microbiologists section. More recently, he was a member of the local organization comittee for the french National Infectiologist Days (JNI), in Poitiers (10 -12 June 2020).
He was implicated in several research grants during his Ph.D. and received, in 2019, three research grants in his own name, including the European Society for Clinical Microbiology and Infectious Diseases.
Since in Ph.D., he is especially interested in Microbial communities, described using new technologies of Sequencing, with a special focus on minor variants with particular properties.